<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154932</url>
  </required_header>
  <id_info>
    <org_study_id>AB123</org_study_id>
    <nct_id>NCT02154932</nct_id>
  </id_info>
  <brief_title>Single Versus Double Dose Intra-vaginal Prostaglandin E2 &quot;Misoprostol&quot; Prior Abdominal Myomectomy</brief_title>
  <official_title>Single Versus Double Dose Intra-vaginal Prostaglandin E2 &quot;Misoprostol&quot; Prior Abdominal Myomectomy: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: The study aimed to investigate the effectiveness of a single versus double dose
      of Prostaglandin E2 &quot;Misoprostol, 400 microgram&quot; during myomectomy for multiple uterine
      fibroids. This was a prospective randomized controlled trial comprised of 69 patients with
      multiple myomas undergoing myomectomy. Patients randomly allocated to either an intra-vaginal
      single dose of 400 microgram Misoprostol 1 hour pre-operatively (group A, 34 cases) or 2
      doses, 3 and 1 hours, prior surgery (group B, 35 cases). Operation time, intra and
      post-operative blood loss, hemoglobin concentration, blood pressure and body's temperature
      were estimated and compared in both groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the operative time</measure>
    <time_frame>from skin to skin in minutes</time_frame>
    <description>The time from start till end of surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>intra and post-operative blood loss</measure>
    <time_frame>during and 6 hours after surgery</time_frame>
    <description>collected soaked towels and sucked blood</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Prostaglandin E2 &quot;Misoprostol&quot; Prior Abdominal Myomectomy</condition>
  <arm_group>
    <arm_group_label>double dose misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 doses, 3 and 1 hours, prior surgery (group B, 35 cases).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>single dose Misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intra-vaginal single dose of 400 microgram Misoprostol 1 hour pre-operatively (group A, 34 cases)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2 doses 400 microgram misoprostol</intervention_name>
    <description>2 doses 400 microgram misoprostol, 3 and 1 hours</description>
    <arm_group_label>double dose misoprostol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>single dose misoprostol</intervention_name>
    <description>1 dose, 1 hours, prior surgery</description>
    <arm_group_label>single dose Misoprostol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients had symptomatic multiple uterine fibroids (abnormal vaginal bleeding,
             lower abdominal dull aching pain and pelvic heaviness, subfertility or recurrent
             abortion)

        Exclusion Criteria:

          -  hypertension, cardiac and pulmonary disease, chronic endocrine or metabolic diseases
             such as diabetes, obesity (body mass index &gt;30 kg/m2), all cases of single myoma and
             those known to be allergic to prostaglandin preparations.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2014</study_first_submitted>
  <study_first_submitted_qc>May 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>May 31, 2014</last_update_submitted>
  <last_update_submitted_qc>May 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>ahmed M. badawy</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Myomectomy, Misoprostol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

